ELOX Eloxx Pharmaceuticals, Inc.
Healthcare · Biological Products, (No Diagnostic Substances) · Market cap: $53.1M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
No open-market insider trades in the last 5 years.
Bought$36.0K1 buy day
Sold$00 sell days
Net insider flow+$36.0Knet buying · 5 years
Latest trade2021-11-29Geffken Daniel E.
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2021-11-29 | Buy | Geffken Daniel E. | CFO | 50,000 | $0.72 | $36.0K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Geffken Daniel E. | CFO | $36.0K | $0 | 2021-11-29 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2021-05-13 | 4 | $27.3M | 53 | +47.4% (+52.2% raw) | -11.4% (-11.6% raw) | -19.6% (-10.1% raw) | closed |
| 2019-06-24 | 3 | $5.4M | 59 | -19.7% (-16.5% raw) | -51.8% (-51.3% raw) | -35.7% (-25.5% raw) | closed |
| 2018-03-21 → 2018-05-22 | 8 | $14.5M | 59 | +7.5% (+8.1% raw) | +96.9% (+100.7% raw) | +57.4% (+69.4% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.